AB Science SA
PAR:AB
AB Science SA
Research & Development
AB Science SA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AB Science SA
PAR:AB
|
Research & Development
-€3.2m
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
16%
|
|
|
Sanofi SA
PAR:SAN
|
Research & Development
-€7.8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
Ipsen SA
PAR:IPN
|
Research & Development
-€728.1m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-14%
|
|
|
Vetoquinol SA
PAR:VETO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Virbac SA
PAR:VIRP
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medincell SA
PAR:MEDCL
|
Research & Development
-€24.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
AB Science SA
Glance View
AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. The company is headquartered in Paris, Ile-De-France and currently employs 96 full-time employees. The company went IPO on 2010-04-21. The company is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The firm is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.
See Also
What is AB Science SA's Research & Development?
Research & Development
-3.2m
EUR
Based on the financial report for Jun 30, 2025, AB Science SA's Research & Development amounts to -3.2m EUR.
What is AB Science SA's Research & Development growth rate?
Research & Development CAGR 10Y
16%
Over the last year, the Research & Development growth was 45%. The average annual Research & Development growth rates for AB Science SA have been 39% over the past three years , 23% over the past five years , and 16% over the past ten years .
